Immunic Appoints Jaa Roberson as Chief People Officer

Immunic appointed Jaa Roberson as Chief People Officer, effective immediately. Roberson will lead global talent and organizational strategy as the company prepares for its Phase 3 ENSURE readout in relapsing multiple sclerosis by end of 2026 and potential regulatory filings and commercialization of vidofludimus calcium. She reports to CEO Erik Lundgren and joins from Day One Biopharmaceuticals, where she helped scale the organization from clinical to commercial stage. Immunic granted her an initial equity option for 190,000 shares vesting over four years.